The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope

Virology

Volumn 224, Issue 2, 1996, Pages 415-426

  Palker, Thomas J ^a   Muir, Andrew J ^a   Spragion, Derry E ^a   Staats, Herman F ^a   Langlois, Alphonse ^a   Montefior, David C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; SYNTHETIC PEPTIDE; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS NEUTRALIZATION;

ANIMALIA; CAPRA HIRCUS; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0030588215     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0548     Document Type: Article

References (64)

1. Almond, N., Jenkins, A., Heath, A. B., Taffs, L. F., and Kitchin, P. (1992). The genetic evolution of the envelope gene of simian immunodeficiency virus in cynomolgus macaques infected with a complex virus pool. Virology 191, 996-1002.
2. Barré-Sinoussi, J. C., Chermann, J. C., Rey, F., Nugeyre, M. T., Charmaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220, 868-870.
3. Benichou, S., Legrand, R., Nakagawa, N., Faure, T., Traincard, F., Vogt, G., Dormont, D., Tiollais, P., Kieny, M.-P., and Madaule, P. (1992). Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 8, 1165-1170.
4. Benichou, S., Venet, A., Beyer, C., Tiollais, P., and Madaule, P. (1993). Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus. Virology 194, 870-874.
5. Beretta, A., Grassi, F., Pelagi, M., Clivio, A., Parravicini, C., Giovinazzo, G., Andronico, F., Lopalco, L., Verani, P., Buttò, S., Titti, F., Rossi, G. B., Viale, G., Ginelli, E., and Siccardi, A. G. (1987). HIV env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation. Eur. J. Immunol. 17, 1793-1798.
6. Björling, E., Broliden, K., Bernardi, D., Utter, G.,Thorstensson, R., Choidi, F., and Norrby, E. (1991). Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc. Natl. Acad. Sci. USA 88, 6082-6086.
7. Björling, E., Chiodi, F., Utter, G., and Norrby, E. (1994). Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2. J. Immunol. 152, 1952-1959.
8. Boeri, E., Giri, A., Lillo, F., Ferari, G., Varnier, O. E., Ferro, A., Sabbatani, S., Saxinger, W. C., and Franchini, G. (1992). In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J. Virol. 66, 4546-4550.
9. Bou-Habib, D. C., Roderiquez, G., Oravecz, T., Berman, P. W., Lusso, P., and Norcross, M. A. (1994). Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68, 6006-6013.
10. Broder, C. C., Earl, P. L., Long, D., Abedon, S. T., Moss, B., and Doms, R. W. (1994). Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and -sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA 91, 11699-11703.
11. Burns, D. P. W., and Desrosiers, R. C. (1991). Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65, 1843-1854.
12. Campbell, B. J., and Hirsch, V. M. (1994). Extensive envelope heterogeneity of simian immunodeficiency virus in tissues from infected macaques. J. Virol. 68, 3129-3137.
13. Cann, A. J., Churcher, M. J., Boyd, M., O'Brien, W., Zhao, J-Q., Zack, J., and Chen, I. S. Y. (1992). The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J. Virol. 66, 305-309.
14. Chakrabarti, L., Guyader, M., Alison, M., Daniel, M. D., Desrosiers, R. C., Tiollais, P., and Sonigo, P. (1987). Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (London) 328, 543-547.
15. Cianciolo, G. J., Copeland, T. D., Oroszlan, S., and Snyderman, R. (1985). Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230, 453-455.
16. Daniel, M. B., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Hunt, D., Kanki, P. J., Essex, M., and Desrosiers, R. C. (1985). Isolation of T-cell tropic HTLV-III like retrovirus from macaques. Science 228, 1202-1204.
17. Franchini, G., Gurgo, C., Guo, H.-G., Gallo, R. C., Collalti, E., Fargnoli, K. A., Hall, L. F., Wong-Staal, F., and Reitz, M. S. (1987). Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature (London) 328, 539-547.
18. Gao, F., Yue, L., White, A. T., Pappas, P. G., Barchue, J., Hanson, A. P., Greene, B. M., Sharp, P. M., Shaw, G. M., and Hahn, B. H. (1992). Human infection by genetically diverse SIVsm-related HIV-2 in West Africa. Nature (London) 358, 495-499.
19. Gardner, M. B., and Luciw, P. A. (1988). Simian immunodeficiency viruses and their relationship to the human immunodeficiency viruses. AIDS 2(Suppl.), S3-S10.
20. Golding, H., Shearer, G. M., Hillman, K., Lucas, P., Manischewitz, J., Zajac, R. A., Clerici, M., Gress, R. E., Boswell, R. N., and Golding, B. (1989). Common epitope in human immunodeficiency virus (HIV) 1 gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV 1-infected individuals. J. Clin. Invest. 83, 1430-1435.
21. Goudsmit, J., Debouck, C., Meloen, R. H., Smit, L., Bakker, M., Asher, D. M., Wolff, A. V., Gibbs, C. J., Jr., and Gajdusek, D. C. (1988). Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85, 4478-4482.
22. Green, N., Alexander, H., Olson, A., Alexander, S., Shinnick, T. M., Sutcliffe, J. G., and Lerner, R. H. (1982). Immunogenic nature of the influenza virus hemagglutinin. Cell 28, 477-487.
23. Haigwood, N., Misher, L., Chin, S. M., Blair, M., Planelles, V., Scandella, C. J., Steimer, K. S., Gardner, M. B., Yilma, T., and Johnson, P. R. (1992). Characterization of group specific antibodies in primates: Studies with SIV envelope in macaques. J. Med. Primatol. 21, 82-90.
24. Haynes, B. F., Arthur, L. A., Frost, P., Matthews, T. J., Langlois, A. J., Palker, T. J., Hart, M. K., Scearce, R. M., Jones, D. M., McDanal, C., Bolognesi, D. P., and Weinhold, K. J. (1993). Conversion of an immunogenic HIV envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein. J. Exp. Med. 177, 717-727.
25. Hirsch, V. M., Martin, J. E., Dapolito, G., Elkins, W. R., London, W. T., Goldstein, S., and Johnson, P. R. (1994). Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J. Virol. 68, 2649-2661.
26. Hirsch, V. M., Olmsted, R. A., Murphey-Corb, M., Purcell, R. H., and Johnson, P. R. (1989). An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (London) 339, 389-392.
27. Holmes, E. C., Zhang, L. Q., Simmonds, P., Ludlam, C. A., and Brown, A. J. L. (1992). Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89, 4835-4839.
28. Hwang, S. S., Boyle, T. J., Lyerly, H. K., and Cullen, B. R. (1992). Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257, 535-537.
29. Javaherian, K., Langlois, A. J., Schmidt, S., Kaufmann, M., Cates, N., Langedijk, J. P. M., Meloen, R. H., Desrosiers, R. C., Burns, D. P. W., Bolognesi, D. P., LaRosa, G. L., and Putney, S. D. (1992). The principal neutralizing determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 1418-1422.
30. Javaherian, K., Langlois, A. J., Montefiori, D. C., Kent, K. K., Ryan, K. A., Wyman, P. D., Stott, J., Bolognesi, D. P., Murphey-Corb, M., and LaRosa, G. J. (1994). Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J. Virol. 68, 2624-2631.
31. Johnson, P. R., Hamm, T. E., Goldstein, S., Kitov, S., and Hirsch, V. M. (1991). The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology185, 217-228.
32. Kent, K. K., Gritz, L., Stallard, G., Cranage, M. P., Collignon, C., Thiriart, C., Corcoran, T., Silvera, P., and Stott, E. J. (1991). Production of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS 5, 829-836.
33. Kent, K. K., Rud, E., Corcoran, T., Powell, C., Thiriart, C., Collignon, C., and Stott, E. J. (1992). Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8, 1147-1151.
34. Kinney-Thomas, E., Weber, J. N., McClure, J., Clapham, P. R., Singhal, M. C., Shriver, M. K., and Weiss, R. A. (1988). Neutralizing monoclonal antibodies to the AIDS virus. AIDS 2, 25-29.
35. Kirchhoff, F., Mori, K., and Desrosiers, R. C. (1994). The "V3" domain is a determinant of simian immunodeficiency virus cell tropism. J. Virol. 68, 3682-3692.
36. Kodama, T., Mori, K., Kawahara, T., Ringler, D., and Desrosiers, R. C. (1993). Analysis in simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J. Virol. 67, 6522-6533.
37. Kornfeld, H., Riedel, N., Viglianti, G. A., Hirsch, V., and Mullins, J. I. (1987). Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (London)326, 610-613.
38. Kyte, J., and Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
39. Langlois, A. J., Weinhold, K. J., Matthews, T. J., and Bolognesi, D. P. (1991). In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVmac251. AIDS Res. Hum. Retroviruses 7, 713-720.
40. Letvin, N. L., Daniel, M. D., Sehgal, P. K., Desrosiers, R. C., Hunt, R. D., Waldron, L. M., MacKey, J. J., Schmidt, D. K., Chalifoux, L. V., and King, N. W. (1985). Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230, 71-73.
41. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M., and Oshiro, L. S. (1984). Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225, 840-842.
42. McBride, B. W., Corthals, G., Rud, E., Kent, K., Webster, S., Cook, N., and Cranage, M. P. (1993). Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac251) induced by infection and vaccination. J. Gen. Virol. 73, 1033-1041.
43. Miller, M. A., Murphey-Corb, M., and Montelaro, R. C. (1992). Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins. AIDS Res. Hum. Retroviruses 8, 1153-1164.
44. Montefiori, D. C., Robinson, W. E., Jr., Schuffman, S. S., and Mitchell, W. M. (1988). Evaluation of antiviral drugs and neutralizing antibodies against human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J. Clin. Microbiol. 26, 231-235.
45. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., III, Burton, D. R., and Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
46. Murphey-Corb, M., Martin, L. N., Rangan, S. R. S., Baskin, G. B., Gormus, B. J., Wolf, R. H., Andes, W. A., West, M., and Montelaro, R. C. (1986). Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (London) 321, 435-437.
47. Myers, G., Wain-Hobson, S., Korber, B., Smith, R. F., and Pavlakis, G. N. (1993). "Human Retroviruses and AIDS 1993." Los Alamos Laboratory, Los Alamos, NM.
48. Overbaugh, J., Rudensey, L. M., Papenhausen, M. D., Benveniste, R. E., and Morton, W. R. (1991). Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65, 7025-7031.
49. Palker, T. J., Clark, N. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R., Bolognesi, D. P., and Haynes, B. F. (1988). Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85, 1932-1936.
50. Palker, T. J., Riggs, E. R., Spragion, D. E., Muir, A., Scearce, R. M., Randall, R. R., McAdams, M., McKnight, A., Clapham, P. R., Weiss, R. A., and Haynes, B. F. (1992). Mapping of homologous, amino-terminal neutralizing regions of human T-lymphotropic virus types I and II (HTLV-I, II) gp46 envelope glycoproteins. J. Virol. 66, 5879-5889.
51. Reiher, W. E., III, Blalock, J. E., and Brunck, T. K. (1986). Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc. Natl. Acad. Sci. USA 83, 9188-9192.
52. Robert-Guroff, M., Aldrich, K., Muldoon, R., Stern, T. L., Bansal, G. P., Matthews, T. J., Markham, P. D., Gallo, R. C., and Franchini, G. (1992). Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J. Virol. 66, 3602-3608.
53. Rusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila, R., Langlois, A., Gallo, R. C., Arthur, L. O., Fischinger, P. J., Bolognesi, D. P., Putney, S. D., and Matthews, T. J. (1988). Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24 amino-acid sequence of the viral envelope gp120. Proc. Natl. Acad. Sci. USA 85, 3198-3202.
54. Samuelsson, A., Björling, E., Putkonen, P., Utter, G., Chiodi, F., and Norrby, E. (1993). Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsm. AIDS 7, 159-165.
55. Shioda, T., Levy, J. A., and Cheng-Mayer, C. (1991). Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (London) 349, 167-169.
56. Siegel, F., Norley, S., Hartung, S., and Kurth, R. (1992). B-cell epitope mapping of the entire SIVagm envelope glycoprotein including fine mapping of immunogenic regions. J. AIDS 5, 583-590.
57. Staats, H. S., Nichols, W. G., and Palker, T. J. (1996). Induction of serum and vaginal anti-HIV-1 antibody responses after intranasal immunization with the C4/V3 peptide T1-SP10MN(A). J. Immunol. 157, 462-472.
58. Sullivan, N., Sun, Y., Li, J., Hoffman, W., and Sodroski, J. (1995). Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69, 4413-4422.
59. Tanchou, V., Sgro-Serpente, P., Durand, H., Aubertin, A. M., Dormont, D., Venet, A., and Benarous, B. (1995). B-cell continuous epitopes of the SIVmac-251 envelope protein in experimentally infected macaques. Res. Virol. 146, 19-32.
60. Torres, J. V., Anderson, D. E., Malley, A., Banapour, B., Axthelm, M. K., Benjamini, E., and Gardner, M. B. (1993). SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques. J. Med. Primatol. 22, 129-137.
61. Torres, J. V., Malley, A., Banapour, B., Anderson, D. E., Axthelm, M. K., Gardner, M. B., and Benjamini, E. (1993). An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in virus neutralization and T-cell activation. AIDS Res. Hum. Retroviruses 9, 423-430.
62. Vancott, T. C., Polonis, V. R., Loomis, L. D., Michael, N. L., Nara, P. L., and Birx, D. L. (1995). Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1. AIDS Res. Hum. Retroviruses 11, 1379-1391.
63. Veronese, F. D., Joseph, B., Copeland, T. D., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. (1989). Identification of simian immunodeficiency virus SIVmac env gene products. J. Virol. 63, 1416-1419.
64. Zagury, J. F., Franchini, G., Reitz, M., Collalti, E., Starcich, B., Hall, L., Fargnoli, K., Jagodzinski, L., Guo, H. G., Laure, F., Arya, S. K., Josephs, S., Zagury, D., and Gallo, R. C. (1988). Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. Proc. Natl. Acad. Sci. USA 85, 5941-5945.